Eloxx Pharmaceuticals, Inc. - Common Stock, $0.01 par value per share (ELOX)

CUSIP: 29014R301

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 5 signals
Share change
+2,499,714
SEC-reported price per share
$13.88
Number of holders
22
Value change
+$34,695,672
Number of buys
22
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
4,076,626

Security key

29014R301

Report period

Q2 2026

Institutions

22

Top holders

10

Ownership snapshot

Top reported holders of ELOX - Eloxx Pharmaceuticals, Inc. - Common Stock, $0.01 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Domicilium Real Estate Fu...
Disclosed value leader
Samsara BioCapital, L.P.
Comparable rows
8/15
Latest evidence
30 Jun 2026
3/4/5 13D/G Lead comparable stake: 20% 7 rows are not safely comparable across share classes. 13D/G row: Domicilium Real Estate Fund III LP Showing 1-6 of 15 holder rows.

Quick read

Domicilium Real Estate Fund III LP leads the comparable SEC ownership view at 20%.

8 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Domicilium Real Estate Fund III LP's linked filing trail.
Comparable ownership Top 5
Domicilium Real Estate Fund III LP 20%
Coastlands Capital LP 10%
Invus Global Management, LLC 10%
Nantahala Capital Management, LLC 9.9%
Aberdeen Group plc 9.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Domicilium Real Estate Fund III LP
3/4/5 13D/G
10%+ Owner · Domicilium Capital Partners LLC
20%
from 13D/G
$4,570,346
1,434,489 shares
mixed-class rows
10 Jun 2026
Coastlands Capital LP
13D/G 3/4/5
10%+ Owner
10%
410,530 shares
$0 10 Jun 2026
Invus Global Management, LLC
13D/G
Raymond Debbane
10%
403,586 shares
$0 09 Jun 2026
Nantahala Capital Management, LLC
13D/G
9.9%
$4,540,000
400,000 shares
$0 30 Jun 2026
Aberdeen Group plc
13D/G
9.9%
400,000 shares
$0 30 Jun 2026
Samsara BioCapital, L.P.
13D/G
Srinivas Akkaraju
9.9%
$4,580,701
403,586 shares
$0 10 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
22
Shares
2,499,714
Rows available
22
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
0
Q2 2026 holders
22
Holder diff
22
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .